[go: up one dir, main page]

EE200200027A - Ambroksooli sisaldav imemistablett - Google Patents

Ambroksooli sisaldav imemistablett

Info

Publication number
EE200200027A
EE200200027A EEP200200027A EEP200200027A EE200200027A EE 200200027 A EE200200027 A EE 200200027A EE P200200027 A EEP200200027 A EE P200200027A EE P200200027 A EEP200200027 A EE P200200027A EE 200200027 A EE200200027 A EE 200200027A
Authority
EE
Estonia
Prior art keywords
tablet
amroxol
lozenge
pressing
amobroxol
Prior art date
Application number
EEP200200027A
Other languages
English (en)
Inventor
M�rz Frieder
Hans-Hermann Von Der Heydt Holger
Schmitt Horst
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7914872&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EE200200027(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of EE200200027A publication Critical patent/EE200200027A/et
Publication of EE04797B1 publication Critical patent/EE04797B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Dry Formation Of Fiberboard And The Like (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Confectionery (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Fats And Perfumes (AREA)
  • Cosmetics (AREA)
EEP200200027A 1999-07-20 2000-07-07 Ambroksooli sisaldav imemistablett EE04797B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19933148A DE19933148A1 (de) 1999-07-20 1999-07-20 Ambroxolhaltige Lutschtablette
PCT/EP2000/006437 WO2001005378A1 (de) 1999-07-20 2000-07-07 Ambroxolhaltige lutschtablette

Publications (2)

Publication Number Publication Date
EE200200027A true EE200200027A (et) 2003-04-15
EE04797B1 EE04797B1 (et) 2007-04-16

Family

ID=7914872

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200027A EE04797B1 (et) 1999-07-20 2000-07-07 Ambroksooli sisaldav imemistablett

Country Status (33)

Country Link
US (1) US6663889B1 (et)
EP (2) EP1352646A3 (et)
JP (1) JP3776041B2 (et)
KR (1) KR100743846B1 (et)
CN (1) CN1164263C (et)
AT (1) ATE246493T1 (et)
AU (1) AU776906B2 (et)
BG (1) BG65503B1 (et)
BR (1) BRPI0012553B8 (et)
CA (1) CA2379314C (et)
CZ (1) CZ301981B6 (et)
DE (2) DE19933148A1 (et)
DK (1) DK1200070T3 (et)
EA (1) EA004044B1 (et)
EE (1) EE04797B1 (et)
ES (1) ES2173823T3 (et)
HK (1) HK1045946B (et)
HR (1) HRP20020050B1 (et)
HU (1) HU229040B1 (et)
IL (2) IL147261A0 (et)
ME (1) MEP36808A (et)
MX (1) MXPA02000546A (et)
NO (1) NO331306B1 (et)
NZ (1) NZ516987A (et)
PL (1) PL197175B1 (et)
PT (1) PT1200070E (et)
RS (1) RS50246B (et)
SI (1) SI1200070T1 (et)
SK (1) SK284290B6 (et)
TR (1) TR200200106T2 (et)
UA (1) UA73313C2 (et)
WO (1) WO2001005378A1 (et)
ZA (1) ZA200200384B (et)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10125883A1 (de) 2001-05-28 2002-12-12 Serumwerk Bernburg Ag Arzneimittel enthaltend einen Effektor des Glutathionmetabolismus zusammen mit alpha-Liponsäure im Rahmen der Nierenersatztherapie
DE10208313A1 (de) * 2002-02-27 2003-09-11 Boehringer Ingelheim Pharma Ambroxol für die Behandlung von schmerzhaften Zuständen im Mund und Rachenraum
US20030166732A1 (en) * 2002-02-27 2003-09-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of painful conditions in the mouth and pharyngeal cavity
US20050075403A1 (en) * 2003-10-02 2005-04-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ambroxol for the treatment of inflammation in the pharynx
ITMI20032463A1 (it) * 2003-12-16 2005-06-17 Advance Holdings Ltd Soluzione acquosa concentrata a base di ambroxolo
GB0409104D0 (en) * 2004-04-23 2004-05-26 Norgine Europe Bv Compressed pharmaceutical compositions
DE102004021992A1 (de) * 2004-05-03 2005-11-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Topische Zubereitung enthaltend Ambroxol
DE102005018561A1 (de) * 2005-04-21 2006-11-02 Giesecke & Devrient Gmbh Verfahren zum Betreiben eines Systems mit einem tragbaren Datenträger und einem Endgerät
DE102010009369A1 (de) 2010-02-25 2011-08-25 Boehringer Ingelheim International GmbH, 55218 Kindergesicherte Verpackung für Ambroxolhaltige Lutschtabletten
AU2011347257A1 (en) 2010-12-23 2013-05-23 Lectio Pharmaentwicklungs- Und Verwertungs Gmbh Aqueous solution of ambroxol
BR112014014808A2 (pt) 2011-12-22 2018-09-25 Centogene Ip Gmbh combinações de um composto que tem a capacidade de reorganizar uma enzima lisossômica e ambroxol e/ou um derivado de ambroxol, sua utilização, preparação farmacêutica e seu método de preparação
US10265280B2 (en) 2016-11-14 2019-04-23 Mingwu Wang Formulations for the treatment of ocular surface diseases and related methods
MX2017014725A (es) * 2017-11-16 2019-05-17 Productos Farm S A De C V Dropropizina en combinacion con ambroxol en la forma farmaceutica de jarabe y tabletas.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3034975C2 (de) * 1980-09-17 1986-11-27 Dr. Karl Thomae Gmbh, 7950 Biberach Arzneimittelkombination zur Behandlung infektiöser Atemwegerkrankungen
DE3485756D1 (de) * 1983-09-17 1992-07-09 Thomae Gmbh Dr K Antiadhaesive prophylactica und arzneimittel enthaltend ein sekretolytisch wirksames benzylaminderivat.
IT1252185B (it) * 1991-12-11 1995-06-05 Therapicon Srl Preparazioni farmaceutiche a liberazione programmata
DE4420735C2 (de) * 1994-06-15 1996-09-05 Allphamed Arzneimittel Gmbh Verfahren zur Herstellung mechanisch stabiler, sich mit hoher Auflösegeschwindigkeit auszeichnender Brausetabletten
DE19648576C2 (de) * 1996-11-23 1999-08-12 Lohmann Therapie Syst Lts Lutschtablette zur modifizierten Freisetzung von Wirkstoffen im Gastrointestinaltrakt

Also Published As

Publication number Publication date
ES2173823T1 (es) 2002-11-01
EA004044B1 (ru) 2003-12-25
MEP36808A (en) 2011-02-10
DE19933148A1 (de) 2001-01-25
PL197175B1 (pl) 2008-03-31
DE50003209D1 (de) 2003-09-11
DK1200070T3 (da) 2003-10-06
KR100743846B1 (ko) 2007-08-02
BR0012553B1 (pt) 2014-05-27
HRP20020050B1 (en) 2004-06-30
EP1352646A2 (de) 2003-10-15
CN1364075A (zh) 2002-08-14
BG65503B1 (bg) 2008-10-31
PT1200070E (pt) 2003-12-31
AU776906B2 (en) 2004-09-23
JP2003522125A (ja) 2003-07-22
EP1200070A1 (de) 2002-05-02
MXPA02000546A (es) 2002-07-30
CZ301981B6 (cs) 2010-08-25
HUP0202021A2 (hu) 2002-11-28
UA73313C2 (uk) 2005-07-15
CA2379314C (en) 2007-09-11
CZ20014633A3 (cs) 2002-03-13
IL147261A0 (en) 2002-08-14
RS50246B (sr) 2009-07-15
SI1200070T1 (en) 2003-12-31
EE04797B1 (et) 2007-04-16
HK1045946A1 (en) 2002-12-20
IL147261A (en) 2006-12-31
HU229040B1 (en) 2013-07-29
US6663889B1 (en) 2003-12-16
EP1200070B1 (de) 2003-08-06
EA200200091A1 (ru) 2002-06-27
NZ516987A (en) 2003-08-29
TR200200106T2 (tr) 2002-07-22
SK812002A3 (en) 2002-06-04
JP3776041B2 (ja) 2006-05-17
WO2001005378A1 (de) 2001-01-25
NO331306B1 (no) 2011-11-21
PL352276A1 (en) 2003-08-11
YU3802A (sh) 2004-09-03
HRP20020050A2 (en) 2003-06-30
AU6269900A (en) 2001-02-05
HUP0202021A3 (en) 2004-05-28
KR20020012316A (ko) 2002-02-15
EP1352646A3 (de) 2004-01-07
BG106316A (en) 2002-08-30
CN1164263C (zh) 2004-09-01
NO20020274D0 (no) 2002-01-18
SK284290B6 (sk) 2005-01-03
ES2173823T3 (es) 2004-04-16
CA2379314A1 (en) 2001-01-25
NO20020274L (no) 2002-03-13
ZA200200384B (en) 2002-10-30
BRPI0012553B8 (pt) 2021-05-25
BR0012553A (pt) 2002-04-16
ATE246493T1 (de) 2003-08-15
HK1045946B (zh) 2005-01-28

Similar Documents

Publication Publication Date Title
DK1200070T3 (da) Ambroxolholdig sugetablet
DE69432789D1 (de) Pharmazeutische zusammensetzungen zur intranasalen verabreichung von apomorphin
ES2067554T3 (es) Aposito de material compuesto para compresion y sujecion.
AR021391A1 (es) Inhaladores presurizados de dosis medidas (mdi) y su uso.
DK0996653T3 (da) Phenolresin til limsammensætning, fremgangsmåde til fremstilling deraf og limsammensætning indeholdende den
ATE318590T1 (de) Arzneimittelkombinationen (z.b. chlorpromazin und pentamidin) zur therapie von neoplastischen erkrankungen
IS2793B (is) Notkun á 3-hýdroxý-3-metýlglútarýl hjálparensíms A afsýringarkljúfshindrum til framleiðslunnar á lyfi til að meðhöndla sykursýkitaugakvilla
EE9700044A (et) Heteroarüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid.
IT1315841B1 (it) Catodo attivato e procedimento per la sua preparazione.
WO2003051293A3 (en) Antidiabetic formulation and method
DE58907866D1 (de) Photopolymerisierbare, zur Herstellung von Druckformen geeignete Druckplatte.
DE3872493D1 (de) Verbundmaterial sowie dazu verwendetes fuellmaterial.
WO2005097064A3 (en) Taste-masked drugs in rupturing multiparticulates
EP0025783A4 (en) PHARMACEUTICAL COMPOSITION FOR USE IN REDUCING THE RATE OF CHOLESTEROL.
ZA971663B (en) Porcine reproductive and respiratory syndrome vaccine.
DK1217999T3 (da) Anvendelse af baclofen til behandling af alkoholisme
NO20031723L (no) Avleveringssystem og fremgangsmåte for å behandle eller forebygge mellomörebetennelse
DE50105258D1 (de) Arzneimittel enthaltend xenon in subanästhetischen konzentrationen zur verwendung als herz-kreislaufmittel
IT8821743A0 (it) Materiali biologici, procedimenti per produrre materiali biologici e per usare tali materiali in terapia.
ATE199495T1 (de) Pharmazeutische zubereitung zur direktverpressung
AR020833A1 (es) Articulo absorbente que comprende una pelicula microporosa ventilada
WO2002057313A8 (en) Receptor-binding compounds and methods for identifying them
AU2003215546A1 (en) Hydrophilic composite material
IT8719938A0 (it) Procedimento per la disidratazione di una miscela di metanolo e alcoli superiori.
AU2001259295A1 (en) Method and composition for rapid delivery of bioactive compounds to the systemiccirculation via the nasal membrane

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20160707